Efruxifermin in Compensated Liver Cirrhosis Caused by MASH.

Saved in:
Bibliographic Details
Title: Efruxifermin in Compensated Liver Cirrhosis Caused by MASH.
Authors: Noureddin M; Houston Methodist Hospital, Houston.; Houston Research Institute, Houston., Rinella ME; University of Chicago Pritzker School of Medicine, Chicago., Chalasani NP; Indiana University School of Medicine, Indianapolis., Neff GW; Covenant Metabolic Specialists, Fort Myers, FL., Lucas KJ; Lucas Research, Morehead City, NC., Rodriguez ME; Florida Research Institute, Lakewood Ranch., Rudraraju M; Pinnacle Clinical Research, San Antonio, TX., Patil R; Pinnacle Clinical Research, San Antonio, TX., Behling C; University of California, San Diego, La Jolla., Burch M; Akero Therapeutics, South San Francisco, CA., Chan DC; Akero Therapeutics, South San Francisco, CA., Tillman EJ; Akero Therapeutics, South San Francisco, CA., Zari A; Akero Therapeutics, South San Francisco, CA., de Temple B; Akero Therapeutics, South San Francisco, CA., Shringarpure R; Akero Therapeutics, South San Francisco, CA., Jain M; Akero Therapeutics, South San Francisco, CA., Rolph T; Akero Therapeutics, South San Francisco, CA., Cheng A; Akero Therapeutics, South San Francisco, CA., Yale K; Akero Therapeutics, South San Francisco, CA.
Source: The New England journal of medicine [N Engl J Med] 2025 Jun 26; Vol. 392 (24), pp. 2413-2424. Date of Electronic Publication: 2025 May 09.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first